+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Veterinary Orthopedic Medicines Market Size, Share & Trends Analysis Report by Product, Animal Type, Application, Route Of Administration, End Use, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 183 Pages
  • June 2024
  • Region: Global
  • Grand View Research
  • ID: 5921090
Description Jump to:
The global veterinary orthopedic medicines market size is expected to reach USD 2.87 billion by 2030, growing at a CAGR of 8.6% from 2024 to 2030. The emergence of regenerative medicine, the rise in adoption of viscosupplements in veterinary medicine, and the surge in uptake of pet insurance are some of the major factors expected to propel market growth. Other factors fueling market growth include advancements in veterinary medicine. According to a study conducted by Boehringer Ingelheim and the American Animal Hospital Association (AAHA), 1 in 5 five dogs, i.e., 20% of all dogs, experience some kind of joint issue in their lifetime. A majority of animals suffer from Osteoarthritis (OA) due to Developmental Orthopedic Diseases (DODs), with certain breeds more prone to malformed joints than others.

Regenerative medicine in veterinary medicine aims to restore normal function of diseased or damaged cells, tissues, etc., including different approaches like cell-based therapies. The use of Mesenchymal Stromal Cells (MSCs), Platelet-rich Plasma (PRP), and autologous serum products is prominent in this field. Currently, these therapies are used in the treatment of tendon, ligament, and joint/cartilage in animals like dogs, horses, & cats. These treatments are primarily research-based, and further concrete clinical reports are under progress. Irrespective of the current use, this branch of veterinary medicine is showing promise for effective treatment & management of veterinary diseases.

Most pet owners are opting for pet insurance to manage the health expenses of their pets. According to a February 2024 article by USA Today, around 26% of the Americans surveyed stated they spend between USD 51 and USD 100 a month on their dogs. On the other hand, several pet insurance companies cover a certain amount of prescription medication. Fetch Pet medication coverage is one of the insurance plans that offers a single plan for illnesses and accidents. The plan covers all prescription drugs for covered conditions, including congenital and chronic ailments like orthopedic problems. According to the North American Pet Health Insurance Association (NAPHIA), as of 2023, there were pet insurance policies worth around USD 3.2 billion in the U.S. Comparably, there were around 4.8 million insured pets in the U.S. at the end of 2022, which was a 22% rise since 2021. Moreover, according to Forbes estimates, in 2023, a veterinary emergency visit for challenges, such as ailments or a broken bone, might cost aroundUSD 1,000. Hence, pet insurance is a necessary tool for covering unforeseen medical expenses.

Current regenerative therapies like MSCs, PRP, etc., fall under the category of drugs. Hence, the FDA regulates them under the category “Cell-based Products”; however, no FDA approval has been given to any of these therapies till now, and the current use falls under FDA investigational exemption. In addition, technological advancements revolutionized veterinary orthopedic medicine by introducing innovative treatments and procedures. Novel technologies, such as advanced imaging, gene editing, and stem cell therapies, enable more precise & effective interventions in animal health. These technological breakthroughs enhance the diagnostic and treatment capabilities of veterinarians, providing advanced solutions for conditions that were previously challenging to address.

Veterinary Orthopedic Medicines Market Report Highlights

  • The pharmaceuticals segment dominated the market with a 46.5% share in 2023 due to the high adoption of products, such as NSAIDS, steroids, etc., in the treatment of veterinary orthopedic complications.
  • The canine segment is expected to grow at the fastest CAGR over the forecast period due to the high prevalence of OA in dogs, the high market adoption, and the rise in sports injuries among dogs.
  • The OA segment held the largest market share in 2023.
  • However, the joint inflammation/pain segment is anticipated to witness the fastest growth over the forecast period.
  • North America dominated the global veterinary orthopedic medicines market due to the increasing prevalence of OA, well-equipped veterinary care infrastructure, government support for quality animal care, and increasing pet adoption in the U.S.

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players worldwide.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listing for you to stay ahead of the curve
  • COVID-19's impact and how to sustain in these fast-evolving markets

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Animal Type
1.2.3. Application
1.2.4. Route of administration
1.2.5. End Use
1.2.6. Regional scope
1.2.7. Estimates and forecasts timeline.
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product
2.2.2. Animal Type
2.2.3. Application
2.2.4. Route of administration
2.2.5. End Use
2.2.6. Regional scope
2.3. Competitive Insights
Chapter 3. Veterinary Orthopedic Medicines Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Drivers Analysis
3.2.1.1. Rising prevalence of orthopedic problems
3.2.1.2. Growing uptake of pet insurance
3.2.1.3. Increase in ageing animal population
3.2.1.4. Advancements in veterinary orthopedic medicines
3.2.2. Market Restraints Analysis
3.2.2.1. Shortage of veterinarians
3.2.2.2. High treatment cost
3.3. Veterinary Orthopedic Medicines Market Analysis Tools
3.3.1. Porter’s Analysis
3.3.2. PESTEL Analysis
Chapter 4. Veterinary Orthopedic Medicines Market: Product Estimates & Trend Analysis
4.1. Animal Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Veterinary Orthopedic Medicines Market: Product Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
4.5. Biologics
4.5.1. Biologics Market, 2018 to 2030 (USD Million)
4.6. Viscosupplements
4.6.1. Viscosupplements Market, 2018 to 2030 (USD Million)
4.7. Pharmaceuticals
4.7.1. Pharmaceuticals Market, 2018 to 2030 (USD Million)
Chapter 5. Veterinary Orthopedic Medicines Market: Animal Type Estimates & Trend Analysis
5.1. Animal Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Veterinary Orthopedic Medicines Market: Animal Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Canine
5.5.1. Canine Market, 2018 to 2030 (USD Million)
5.6. Equine
5.6.1. Equine Market, 2018 to 2030 (USD Million)
5.7. Others
5.7.1. Others Market, 2018 to 2030 (USD Million)
Chapter 6. Veterinary Orthopedic Medicines Market: Application Estimates & Trend Analysis
6.1. Application Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Veterinary Orthopedic Medicines Market: Application Outlook
6.4. Osteoarthritis
6.4.1. Osteoarthritis Market, 2018 to 2030 (USD Million)
6.5. Degenerative Joint Disease (DJD)
6.5.1. Degenerative Joint Disease (DJD) Market, 2018 to 2030 (USD Million)
6.6. Other Applications
6.6.1. Other Applications Market, 2018 to 2030 (USD Million)
Chapter 7. Veterinary Orthopedic Medicines Market: Route of Administration Estimates & Trend Analysis
7.1. Route of Administration Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Veterinary Orthopedic Medicines Market: Route of Administration Outlook
7.4. Oral
7.4.1. Oral Market, 2018 to 2030 (USD Million)
7.5. Injectable
7.5.1. Injectable Market, 2018 to 2030 (USD Million)
7.6. Others
7.6.1. Others Market, 2018 to 2030 (USD Million)
Chapter 8. Veterinary Orthopedic Medicines Market: End use Estimates & Trend Analysis
8.1. End Use Market Share, 2023 & 2030
8.2. Segment Dashboard
8.3. Veterinary Orthopedic Medicines Market: End user Outlook
8.4. Veterinary Hospitals
8.4.1. Veterinary Hospitals Market, 2018 to 2030 (USD Million)
8.5. Veterinary Clinics
8.5.1. Veterinary Clinics Market, 2018 to 2030 (USD Million)
8.6. Others
8.6.1. Others Market, 2018 to 2030 (USD Million)
Chapter 9. Veterinary Orthopedic Medicines Market: Regional Estimates & Trend Analysis
9.1. Veterinary Orthopedic Medicines Market Share, By Region, 2023 & 2030 (USD Million)
9.2. North America
9.2.1. Market Estimates and Forecasts, 2018-2030 (USD Million)
9.2.2. U.S.
9.2.2.1. Key Country Dynamics
9.2.2.2. Regulatory Landscape/Reimbursement Scenario
9.2.2.3. Competitive Insights
9.2.2.4. U.S. Market Estimates and Forecasts, 2018-2030
9.2.3. Canada
9.2.3.1. Key Country Dynamics
9.2.3.2. Regulatory Landscape/Reimbursement Scenario
9.2.3.3. Competitive Insights
9.2.3.4. Canada Market Estimates and Forecasts, 2018-2030
9.3. Europe
9.3.1. Europe Market Estimates and Forecasts, 2018-2030
9.3.2. UK
9.3.2.1. Key Country Dynamics
9.3.2.2. Regulatory Landscape/Reimbursement Scenario
9.3.2.3. Competitive Insights
9.3.2.4. UK Market Estimates and Forecasts, 2018-2030
9.3.3. Germany
9.3.3.1. Key Country Dynamics
9.3.3.2. Regulatory Landscape/Reimbursement Scenario
9.3.3.3. Competitive Insights
9.3.3.4. Germany Market Estimates and Forecasts, 2018-2030
9.3.4. France
9.3.4.1. Key Country Dynamics
9.3.4.2. Regulatory Landscape/Reimbursement Scenario
9.3.4.3. Competitive Insights
9.3.4.4. France Market Estimates and Forecasts, 2018-2030
9.3.5. Italy
9.3.5.1. Key Country Dynamics
9.3.5.2. Regulatory Landscape/Reimbursement Scenario
9.3.5.3. Competitive Insights
9.3.5.4. Italy Market Estimates and Forecasts, 2018-2030
9.3.6. Spain
9.3.6.1. Key Country Dynamics
9.3.6.2. Regulatory Landscape/Reimbursement Scenario
9.3.6.3. Competitive Insights
9.3.6.4. Spain Market Estimates and Forecasts, 2018-2030
9.3.7. Denmark
9.3.7.1. Key Country Dynamics
9.3.7.2. Regulatory Landscape/Reimbursement Scenario
9.3.7.3. Competitive Insights
9.3.7.4. Denmark Market Estimates and Forecasts, 2018-2030
9.3.8. Sweden
9.3.8.1. Key Country Dynamics
9.3.8.2. Regulatory Landscape/Reimbursement Scenario
9.3.8.3. Competitive Insights
9.3.8.4. Sweden Market Estimates and Forecasts, 2018-2030
9.3.9. Norway
9.3.9.1. Key Country Dynamics
9.3.9.2. Regulatory Landscape/Reimbursement Scenario
9.3.9.3. Competitive Insights
9.3.9.4. Norway Market Estimates and Forecasts, 2018-2030
9.4. Asia Pacific
9.4.1. Asia Pacific Market Estimates and Forecasts, 2018-2030
9.4.2. Japan
9.4.2.1. Key Country Dynamics
9.4.2.2. Regulatory Landscape/Reimbursement Scenario
9.4.2.3. Competitive Insights
9.4.2.4. Japan Market Estimates and Forecasts, 2018-2030
9.4.3. China
9.4.3.1. Key Country Dynamics
9.4.3.2. Regulatory Landscape/Reimbursement Scenario
9.4.3.3. Competitive Insights
9.4.3.4. China Market Estimates and Forecasts, 2018-2030
9.4.4. India
9.4.4.1. Key Country Dynamics
9.4.4.2. Regulatory Landscape/Reimbursement Scenario
9.4.4.3. Competitive Insights
9.4.4.4. India Market Estimates and Forecasts, 2018-2030
9.4.5. Australia
9.4.5.1. Key Country Dynamics
9.4.5.2. Regulatory Landscape/Reimbursement Scenario
9.4.5.3. Competitive Insights
9.4.5.4. Australia Market Estimates and Forecasts, 2018-2030
9.4.6. Thailand
9.4.6.1. Key Country Dynamics
9.4.6.2. Regulatory Landscape/Reimbursement Scenario
9.4.6.3. Competitive Insights
9.4.6.4. Thailand Market Estimates and Forecasts, 2018-2030
9.4.7. South Korea
9.4.7.1. Key Country Dynamics
9.4.7.2. Regulatory Landscape/Reimbursement Scenario
9.4.7.3. Competitive Insights
9.4.7.4. South Korea Market Estimates and Forecasts, 2018-2030
9.5. Latin America
9.5.1. Latin America Market Estimates and Forecasts, 2018-2030
9.5.2. Brazil
9.5.2.1. Key Country Dynamics
9.5.2.2. Regulatory Landscape/Reimbursement Scenario
9.5.2.3. Competitive Insights
9.5.2.4. Brazil Market Estimates and Forecasts, 2018-2030
9.5.3. Mexico
9.5.3.1. Key Country Dynamics
9.5.3.2. Regulatory Landscape/Reimbursement Scenario
9.5.3.3. Competitive Insights
9.5.3.4. Mexico Market Estimates and Forecasts, 2018-2030
9.5.4. Argentina
9.5.4.1. Key Country Dynamics
9.5.4.2. Regulatory Landscape/Reimbursement Scenario
9.5.4.3. Competitive Insights
9.5.4.4. Argentina Market Estimates and Forecasts, 2018-2030
9.6. Middle East and Africa
9.6.1. Middle East and Africa Market Estimates and Forecasts, 2018-2030
9.6.2. South Africa
9.6.2.1. Key Country Dynamics
9.6.2.2. Regulatory Landscape/Reimbursement Scenario
9.6.2.3. Competitive Insights
9.6.2.4. South Africa Market Estimates and Forecasts, 2018-2030
9.6.3. Saudi Arabia
9.6.3.1. Key Country Dynamics
9.6.3.2. Regulatory Landscape/Reimbursement Scenario
9.6.3.3. Competitive Insights
9.6.3.4. Saudi Arabia Market Estimates and Forecasts, 2018-2030
9.6.4. UAE
9.6.4.1. Key Country Dynamics
9.6.4.2. Regulatory Landscape/Reimbursement Scenario
9.6.4.3. Competitive Insights
9.6.4.4. UAE Market Estimates and Forecasts, 2018-2030
9.6.5. Kuwait
9.6.5.1. Key Country Dynamics
9.6.5.2. Regulatory Landscape/Reimbursement Scenario
9.6.5.3. Competitive Insights
9.6.5.4. Kuwait Market Estimates and Forecasts, 2018-2030
Chapter 10. Competitive Landscape
10.1. Recent Developments & Impact Analysis by Key Market Participants
10.2. Company Categorization
10.3. Company Market Share Analysis
10.4. Company Heat Map Analysis
10.5. Strategy Mapping
10.5.1. Expansion
10.5.2. Mergers & Acquisition
10.5.3. Partnerships & Collaborations
10.5.4. New Product Launches
10.5.5. Research And Development
10.6. Company Profiles
10.6.1. Zoetis Inc.
10.6.1.1. Participant’s Overview
10.6.1.2. Financial Performance
10.6.1.3. Product Benchmarking
10.6.1.4. Recent Developments
10.6.2. Boehringer Ingelheim
10.6.2.1. Participant’s Overview
10.6.2.2. Financial Performance
10.6.2.3. Product Benchmarking
10.6.2.4. Recent Developments
10.6.3. Elanco Animal Health
10.6.3.1. Participant’s Overview
10.6.3.2. Financial Performance
10.6.3.3. Product Benchmarking
10.6.3.4. Recent Developments
10.6.4. American Regent, Inc.
10.6.4.1. Participant’s Overview
10.6.4.2. Financial Performance
10.6.4.3. Product Benchmarking
10.6.4.4. Recent Developments
10.6.5. Merck Animal Health (Merck & Co. Inc)
10.6.5.1. Participant’s Overview
10.6.5.2. Financial Performance
10.6.5.3. Product Benchmarking
10.6.5.4. Recent Developments
10.6.6. Vetoquinol S.A.
10.6.6.1. Participant’s Overview
10.6.6.2. Financial Performance
10.6.6.3. Product Benchmarking
10.6.6.4. Recent Developments
10.6.7. Ceva Sante Animale
10.6.7.1. Participant’s Overview
10.6.7.2. Financial Performance
10.6.7.3. Product Benchmarking
10.6.7.4. Recent Developments
10.6.8. Virbac
10.6.8.1. Participant’s Overview
10.6.8.2. Financial Performance
10.6.8.3. Product Benchmarking
10.6.8.4. Recent Developments
10.6.9. Biogenesis Bago
10.6.9.1. Participant’s Overview
10.6.9.2. Financial Performance
10.6.9.3. Product Benchmarking
10.6.9.4. Recent Developments
10.6.10. Ardent Animal Health LLC.
10.6.10.1. Participant’s Overview
10.6.10.2. Financial Performance
10.6.10.3. Product Benchmarking
10.6.10.4. Recent Developments
10.6.11. Bioiberica S.A.U
10.6.11.1. Participant’s Overview
10.6.11.2. Financial Performance
10.6.11.3. Product Benchmarking
10.6.11.4. Recent Developments
10.6.12. PetVivo Holdings, Inc. (Spryng)
10.6.12.1. Participant’s Overview
10.6.12.2. Financial Performance
10.6.12.3. Product Benchmarking
10.6.12.4. Recent Developments
10.6.13. Contipro A.S.
10.6.13.1. Participant’s Overview
10.6.13.2. Financial Performance
10.6.13.3. Product Benchmarking
10.6.13.4. Recent Developments
10.6.14. VetStem, Inc.
10.6.14.1. Participant’s Overview
10.6.14.2. Financial Performance
10.6.14.3. Product Benchmarking
10.6.14.4. Recent Developments
10.6.15. Enso Discoveries
10.6.15.1. Participant’s Overview
10.6.15.2. Financial Performance
10.6.15.3. Product Benchmarking
10.6.15.4. Recent Developments
10.6.16. Contura Vet US
10.6.16.1. Participant’s Overview
10.6.16.2. Financial Performance
10.6.16.3. Product Benchmarking
10.6.16.4. Recent Developments
10.6.17. T-Cyte Therepeutics
10.6.17.1. Participant’s Overview
10.6.17.2. Financial Performance
10.6.17.3. Product Benchmarking
10.6.17.4. Recent Developments
10.6.18. MEDREGO LLC
10.6.18.1. Participant’s Overview
10.6.18.2. Financial Performance
10.6.18.3. Product Benchmarking
10.6.18.4. Recent Developments
10.6.19. Bimeda U.S.
10.6.19.1. Participant’s Overview
10.6.19.2. Financial Performance
10.6.19.3. Product Benchmarking
10.6.19.4. Recent Developments
10.6.20. Hyalogic
10.6.20.1. Participant’s Overview
10.6.20.2. Financial Performance
10.6.20.3. Product Benchmarking
10.6.20.4. Recent Developments
10.6.21. Hester Biosciences
10.6.21.1. Participant’s Overview
10.6.21.2. Financial Performance
10.6.21.3. Product Benchmarking
10.6.21.4. Recent Developments
List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations
Table 3 North America Veterinary Orthopedic Medicines Market, By Region, 2018-2030 (USD Million)
Table 4 North America Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 5 North America Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 6 North America Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 7 North America Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 8 North America Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 9 U.S. Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 10 U.S. Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 11 U.S. Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 12 U.S. Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 13 U.S. Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 14 Canada Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 15 Canada Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 16 Canada Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 17 Canada Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 18 Canada Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 19 Europe Veterinary Orthopedic Medicines Market, By Region, 2018-2030 (USD Million)
Table 20 Europe Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 21 Europe Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 22 Europe Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 23 Europe Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 24 Europe Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 25 UK Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 26 UK Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 27 UK Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 28 UK Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 29 UK Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 30 Germany Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 31 Germany Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 32 Germany Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 33 Germany Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 34 Germany Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 35 France Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 36 France Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 37 France Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 38 France Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 39 France Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 40 Italy Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 41 Italy Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 42 Italy Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 43 Italy Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 44 Italy Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 45 Spain Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 46 Spain Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 47 Spain Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 48 Spain Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 49 Spain Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 50 Denmark Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 51 Denmark Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 52 Denmark Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 53 Denmark Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 54 Denmark Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 55 Sweden Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 56 Sweden Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 57 Sweden Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 58 Sweden Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 59 Sweden Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 60 Norway Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 61 Norway Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 62 Norway Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 63 Norway Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 64 Norway Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 65 Asia Pacific Veterinary Orthopedic Medicines Market, By Region, 2018-2030 (USD Million)
Table 66 Asia Pacific Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 67 Asia Pacific Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 68 Asia Pacific Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 69 Asia Pacific Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 70 Asia Pacific Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 71 China Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 72 China Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 73 China Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 74 China Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 75 China Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 76 Japan Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 77 Japan Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 78 Japan Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 79 Japan Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 80 Japan Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 81 India Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 82 India Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 83 India Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 84 India Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 85 India Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 86 Australia Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 87 Australia Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 88 Australia Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 89 Australia Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 90 Australia Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 91 South Korea Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 92 South Korea Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 93 South Korea Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 94 South Korea Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 95 South Korea Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 96 Thailand Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 97 Thailand Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 98 Thailand Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 99 Thailand Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 100 Thailand Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 101 Latin America Veterinary Orthopedic Medicines Market, By Region, 2018-2030 (USD Million)
Table 102 Latin America Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 103 Latin America Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 104 Latin America Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 105 Latin America Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 106 Latin America Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 107 Brazil Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 108 Brazil Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 109 Brazil Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 110 Brazil Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 111 Brazil Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 112 Mexico Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 113 Mexico Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 114 Mexico Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 115 Mexico Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 116 Mexico Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 117 Argentina Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 118 Argentina Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 119 Argentina Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 120 Argentina Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 121 Argentina Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 122 MEA Veterinary Orthopedic Medicines Market, By Region, 2018-2030 (USD Million)
Table 123 MEA Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 124 MEA Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 125 MEA Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 126 MEA Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 127 MEA Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 128 South Africa Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 129 South Africa Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 130 South Africa Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 131 South Africa Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 132 South Africa Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 133 Saudi Arabia Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 134 Saudi Arabia Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 135 Saudi Arabia Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 136 Saudi Arabia Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 137 Saudi Arabia Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 138 UAE Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 139 UAE Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 140 UAE Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 141 UAE Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 142 UAE Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
Table 143 Kuwait Veterinary Orthopedic Medicines Market, By Product, 2018-2030 (USD Million)
Table 144 Kuwait Veterinary Orthopedic Medicines Market, By Animal Type, 2018-2030 (USD Million)
Table 145 Kuwait Veterinary Orthopedic Medicines Market, Application, 2018-2030 (USD Million)
Table 146 Kuwait Veterinary Orthopedic Medicines Market, Route of Administration, 2018-2030 (USD Million)
Table 147 Kuwait Veterinary Orthopedic Medicines Market, End Use, 2018-2030 (USD Million)
List of Figures
Figure 1 Veterinary Orthopedic Medicines Market Segmentation
Figure 2 Disease Epidemiology
Figure 3 Information Procurement
Figure 4 Data Analysis Models
Figure 5 Market Formulation and Validation
Figure 6 Data Validating & Publishing
Figure 7 Market Snapshot
Figure 8 Segment Snapshot (1/2)
Figure 9 Segment Snapshot (2/2)
Figure 10 Competitive Landscape Snapshot
Figure 11 Veterinary Orthopedic Medicines - Market Size and Growth Prospects (USD Million)
Figure 12 Veterinary Orthopedic Medicines Market: Industry Value Chain Analysis
Figure 13 Veterinary Orthopedic Medicines Market: Market Dynamics
Figure 14 Veterinary Orthopedic Medicines Market: PORTER’s Analysis
Figure 15 Veterinary Orthopedic Medicines Market: PESTEL Analysis
Figure 16 Veterinary Orthopedic Medicines Market Share By Product, 2023 & 2030 (USD Million)
Figure 17 Veterinary Orthopedic Medicines Market, By Product: Market Share, 2023 & 2030
Figure 18 Biologics Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 19 Viscosupplements Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 20 Pharmaceuticals Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 21 Veterinary Orthopedic Medicines Market Share By Animal type, 2023 & 2030 (USD Million)
Figure 22 Veterinary Orthopedic Medicines Market, By Animal type: Market Share, 2023 & 2030
Figure 23 Canine Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 24 Equine Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 25 Others Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 26 Veterinary Orthopedic Medicines Market Share By Application, 2023 & 2030 (USD Million)
Figure 27 Veterinary Orthopedic Medicines Market, By Application: Market Share, 2023 & 2030
Figure 28 Osteoarthritis Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 29 Degenerative Joint Diseases (DJD) Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 30 Others Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 31 Veterinary Orthopedic Medicines Market Share By Route of Administration, 2023 & 2030 (USD Million)
Figure 32 Veterinary Orthopedic Medicines Market, By Route of Administration: Market Share, 2023 & 2030
Figure 33 Oral Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 34 Injectable Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 35 Veterinary Orthopedic Medicines Market, by End User: Key Takeaways
Figure 36 Veterinary Orthopedic Medicines Market, by End User: Market Share, 2023 & 2030
Figure 37 Veterinary Hospitals Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 38 Veterinary Clinics Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 39 Other Market Estimates & Forecasts, 2018-2030 (Revenue, USD Million)
Figure 40 Fig. 39 Veterinary Orthopedic Medicines Market Revenue, by Region, 2023 & 2030 (USD Million)
Figure 41 Regional Marketplace: Key Takeaways
Figure 42 Regional Marketplace: Key Takeaways
Figure 43 North America Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 44 U.S. Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 45 Canada Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 46 Europe Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 47 UK Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030,) (USD Million)
Figure 48 Germany Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 49 France Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 50 Italy Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 51 Spain Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 52 Denmark Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 53 Sweden Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 54 Norway Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 55 Asia Pacific Veterinary Orthopedic Medicines Market Estimates and Forecast, 2018-2030 (USD Million)
Figure 56 China Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 57 Japan Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 58 India Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 59 South Korea Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 60 Australia Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 61 Thailand Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 62 Latin America Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 63 Brazil Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 64 Mexico Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 65 Argentina Veterinary Orthopedic Medicines Market Estimates and Forecasts, 2018-2030 (USD Million)
Figure 66 MEA Market Estimates and Forecasts, 2018-2030
Figure 67 KSA Market Estimates and Forecasts, 2018-2030
Figure 68 UAE Market Estimates and Forecasts, 2018-2030
Figure 69 South Africa Market Estimates and Forecasts, 2018-2030
Figure 70 Kuwait Market Estimates and Forecasts, 2018-2030

Companies Mentioned

  • Zoetis Inc.
  • Boehringer Ingelheim
  • Elanco Animal Health
  • American Regent, Inc.
  • Merck Animal Health (Merck & Co. Inc)
  • Vetoquinol S.A.
  • Ceva Sante Animale
  • Virbac
  • Biogenesis Bago
  • Ardent Animal Health LLC.
  • Bioiberica S.A.U
  • PetVivo Holdings, Inc. (Spryng)
  • Contipro A.S.
  • VetStem, Inc.
  • Enso Discoveries
  • Contura Vet US
  • T-Cyte Therepeutics
  • MEDREGO LLC
  • Bimeda U.S.
  • Hyalogic
  • Hester Biosciences

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages183
PublishedJune 2024
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 1.62 Billion
Forecasted Market Value ( USD ) by 2030 $ 2.87 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned21

Related Topics

Related Reports

Veterinary Orthopedics Market by Product Type, Application, End-use - Global Forecast 2025-2030 - Product Image

Veterinary Orthopedics Market by Product Type, Application, End-use - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Veterinary orthopedic Medicine Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F - Product Image

Veterinary orthopedic Medicine Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

  • Report
  • 183 Pages
  • Global
From
Veterinary Orthopedics Market Size, Share & Trends Analysis Report By Application (TPLO, TTA, Joint Replacement, Trauma), By Animal (Canine, Feline), By Product (Implants, Instruments), By End-use (Veterinary Hospitals & Clinics), By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Veterinary Orthopedics Market Size, Share & Trends Analysis Report By Application (TPLO, TTA, Joint Replacement, Trauma), By Animal (Canine, Feline), By Product (Implants, Instruments), By End-use (Veterinary Hospitals & Clinics), By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 163 Pages
  • Global
From
Veterinary Orthopedic Medicine Global Market Report 2024 - Product Image

Veterinary Orthopedic Medicine Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Veterinary Orthopedic Implants Market by Product, Application, End-user - Global Forecast 2025-2030 - Product Image

Veterinary Orthopedic Implants Market by Product, Application, End-user - Global Forecast 2025-2030

  • Report
  • 197 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.